Growing nanotech company launches new identity as MIP Discovery


New MIP discovery identity

MIP Diagnostics, a leading UK nanotechnology company, today changed its name to MIP Discovery as the company continues to expand into the healthcare sector.

BEDFORD, BEDFORDSHIRE, UNITED KINGDOM, May 18, 2022 / — Based in Bedfordshire, MIP Diagnostics has been the market leader in the commercialization of molecularly imprinted polymers (MIPs) since its inception in 2015. A strong portfolio intellectual property and a team of industry experts has ensured rapid market growth in medical diagnostics, and the company is now expanding into the broader healthcare sector under the new identity of MIP Discovery.

Molecularly imprinted polymers are a new type of nanoparticle designed to mimic antibodies for use in diagnostic tests and other applications. They are completely animal-free and are able to target markers that are historically difficult for biological affinity reagents such as antibodies. Their unique characteristics have fueled great success in the fields of in vitro diagnostics (IVD), and the company is now bringing the technology to the broader healthcare market, including drug addiction testing, food safety testing and the manufacture of cell and gene therapies. The new name represents the broader scope of MIPs and positions the company for continued growth. The name change comes at a time when the company has already attracted accelerated financial backing, with a recent oversubscribed investment round totaling £7.3m.

Stéphane Argivier, CEO of MIP Diagnostics, commented on the name change: “We are very proud to have transitioned to a customer-focused professional organization. We have assembled a team with significant industry experience and have achieved product, industrial and commercial validation of our patented technology, supported by great people and cutting-edge molecular modeling capabilities.As we continue our journey and drive market adoption in our areas of focus in the next generation of IVDs, industrial sensors and cell and gene therapy bioprocessing, it is important that our identity also evolves with us, which is why we have changed our name from MIP Diagnostics to MIP Discovery.”

He added, “The new name represents our differentiated technology and resonates with our innovative customer base, primarily blue-chip companies, who are dedicated to discovering new ways to improve people’s quality of life.

Keli Stockbridge
MIP Discovery
+441234589725 ext.
[email protected]
Visit us on social media:


Comments are closed.